Literature DB >> 2052727

Seminal vesicle cysts: association with adult polycystic kidney disease.

M B Alpern1, R E Dorfman, B H Gross, C A Gottlieb, M A Sandler.   

Abstract

Adult polycystic kidney disease (APKD) is associated with cyst formation in the kidney, liver, pancreas, esophagus, ovary, uterus, and brain. Four patients with APKD (aged 45-65 years) with computed tomographic evidence of seminal vesicle cysts are described. All seminal vesicles contained cystic masses with attenuation values of 0-30 HU. Seminal vesicle thickness was 3-4 cm (normal, 1.5 cm). High-attenuation walls separated the cysts, which were 3-35 mm in diameter. All patients had typical renal stigmata of APKD. None had cysts elsewhere, except one patient with hepatic cysts. Postmortem examination in one patient confirmed the seminal vesicle cysts as well as APKD. It is likely that a basement membrane defect allows cyst formation in multiple organs, presumably including the seminal vesicles. Because of the association of seminal vesicle cysts with ipsilateral urogenital anomalies, and because only 60% of patients with APKD have a relevant familial history, the kidneys of patients with cross-sectional imaging evidence of seminal vesicle cysts should also be studied.

Entities:  

Mesh:

Year:  1991        PMID: 2052727     DOI: 10.1148/radiology.180.1.2052727

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.

Authors:  Allison L Brill; Barbara E Ehrlich
Journal:  Cell Signal       Date:  2019-12-02       Impact factor: 4.315

Review 2.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

3.  Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Bairbre A McNicholas; Yoshida Kotaro; William Martin; Ayush Sharma; Patrick S Kamath; Marie E Edwards; Walter K Kremers; Suresh T Chari; Vicente E Torres; Peter C Harris; Naoki Takahashi; Marie C Hogan
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

4.  Incremental health care resource utilization and expenditures associated with autosomal-dominant polycystic kidney disease.

Authors:  Neeraj N Iyer; Nicholas J Vendetti; Daniel I Levy; Jack Mardekian; Marko A Mychaskiw; Joseph Thomas
Journal:  Clinicoecon Outcomes Res       Date:  2018-10-31

Review 5.  Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.

Authors:  Aryendu Kumar Saini; Rakesh Saini; Shubham Singh
Journal:  Mol Med       Date:  2020-12-11       Impact factor: 6.354

6.  Polycystin 2 is increased in disease to protect against stress-induced cell death.

Authors:  Allison L Brill; Tom T Fischer; Jennifer M Walters; Arnaud Marlier; Lorenzo R Sewanan; Parker C Wilson; Eric K Johnson; Gilbert Moeckel; Lloyd G Cantley; Stuart G Campbell; Jeanne M Nerbonne; Hee Jung Chung; Marie E Robert; Barbara E Ehrlich
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.